# ICATIBANT

NDC: 69097-664
Generic name: ICATIBANT
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20200713

FDA application: ANDA212446

## Active ingredients

- ICATIBANT ACETATE: 30 mg/3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-664"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-664
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ccbb5e50-ce56-4898-aa1a-f1c1f3d312f6